Related Experiment Video
Updated: Jun 7, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
Inflammation, immunity, and vaccines for Helicobacter.
Toni Aebischer1, Thomas F Meyer, Leif P Andersen
1Robert Koch-Institute, Nordufer 20, Berlin, Germany. AebischerA@rki.de
Understanding Helicobacter pylori infection requires studying host immune interactions. New research highlights small noncoding RNAs and T helper 17 cells for effective vaccine development against this common pathogen.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Helicobacter pylori is a primary cause of gastritis, ulcers, gastric cancer, and lymphoma.
- Infection outcomes depend on complex host-pathogen immune interactions.
- Recent research explores novel immune regulators and detection mechanisms.
Purpose of the Study:
- To review recent advancements in understanding the immunology of Helicobacter pylori infection.
- To highlight the role of small noncoding RNAs and innate pattern recognition receptors.
- To assess the contribution of T helper cell subsets, particularly Th17 cells, in vaccine development.
Main Methods:
- Review of recent scientific literature on Helicobacter pylori immunology.
- Analysis of studies investigating innate immune detection of H. pylori.
- Evaluation of research on CD4 T helper cell subsets and their role in protective immunity.
Main Results:
- Small noncoding RNAs are identified as novel regulators of the immune response to H. pylori.
- New insights into how innate pattern recognition receptors detect H. pylori infection.
- Th17 cells are crucial for effective cell-mediated immunity and vaccination against H. pylori.
- Cost-effectiveness of vaccination strategies has been re-assessed and confirmed.
Conclusions:
- Deciphering host-pathogen interactions is key to predicting, treating, and preventing H. pylori-related diseases.
- Targeting Th17 cell induction and function is a promising strategy for developing effective H. pylori vaccines.
- New vaccine antigens, formulations, and delivery methods are being explored to enhance protective immunity.
More Related Videos
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Related Concept Videos
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Microorganisms in Medicine and Therapeutics
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Vaccinations